Hasselt University
Hasselt, 3500, Belgium
NCT Number: NCT03938558
This study is a controlled pilot study with 17 participants with Multiple Sclerosis (MS). The primary goal of this study is to objectively examine the effects of a multimodal dance intervention on walking-related performance fatigability. The secondary aim is to investigate the effects of a multimodal dance intervention on other MS symptoms related to fatigue and fatigability.
The following research questions will be addressed:
1. Does a multimodal dance intervention have positive effects on walking-related fatigability? 2. Does a multimodal dance intervention have positive effects on other MS symptoms related to fatigue and fatigability?
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Hasselt, 3500, Belgium
This study distinguish two groups contributing to a dance and art production. The experimental group will perform 10 weeks of dance training, while the other group will contribute to the production in various ways (e.g. word art, photography, painting, …).
Measures will be taken before and after the training or assistance in the production.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The experimental group will perform 10 weeks of dance training
The other group will contribute to the production in various ways (e.g. word art, photography, painting, …)
Time frame: Baseline
Performance motor fatigability: Calculating the Distance Walked Index (DWI) during 6MWT.
Formula for walking-related performance fatigability: DWI = ([Distance walked at minute 6 - Distance walked at minute 1]/Distance walked at minute 1) × 100
Time frame: week 10
Performance motor fatigability: Calculating the Distance Walked Index (DWI) during 6MWT.
Formula for walking-related performance fatigability: DWI = ([Distance walked at minute 6 - Distance walked at minute 1]/Distance walked at minute 1) × 100
Time frame: week 20
Performance motor fatigability: Calculating the Distance Walked Index (DWI) during 6MWT.
Formula for walking-related performance fatigability: DWI = ([Distance walked at minute 6 - Distance walked at minute 1]/Distance walked at minute 1) × 100
Time frame: baseline
Modified Fatigue Impact Scale (MFIS)
Time frame: week 10
Modified Fatigue Impact Scale (MFIS)
Time frame: week 20
Modified Fatigue Impact Scale (MFIS)
Time frame: baseline
seated bipedal coordination task (knee flexion and extension movements during 6 minutes, and metronome based 0,75 Hz, 1Hz and 1,5 Hz for 1 minute)
Time frame: week 10
seated bipedal coordination task (knee flexion and extension movements during 6 minutes, and metronome based 0,75 Hz, 1Hz and 1,5 Hz for 1 minute)
Time frame: week 20
seated bipedal coordination task (knee flexion and extension movements during 6 minutes, and metronome based 0,75 Hz, 1Hz and 1,5 Hz for 1 minute)
Time frame: Baseline
VAS increase minute per minute during 6MWT (range 0-10)
Time frame: week 10
VAS increase minute per minute during 6MWT (range 0-10)
Time frame: week 20
VAS increase minute per minute during 6MWT (range 0-10)
Time frame: Baseline
PASAT and SDMT total score and correct answers last ⅓ vs first ⅓
Time frame: week 10
PASAT and SDMT total score and correct answers last ⅓ vs first ⅓
Time frame: week 20
PASAT and SDMT total score and correct answers last ⅓ vs first ⅓
Time frame: Baseline
Fatigue Severity Scale (FSS) : range 1-7
Time frame: week 10
Fatigue Severity Scale (FSS) : range 1-7
Time frame: week 20
Fatigue Severity Scale (FSS) : range 1-7
Time frame: Baseline
Impact of MS via a questionnaire. 29 items, total score on 145.
Time frame: week 10
Impact of MS via a questionnaire. 29 items, total score on 145.
Time frame: week 20
Impact of MS via a questionnaire. 29 items, total score on 145.
Time frame: Baseline
Quality of Life health related questionnaire. Scale 0-100
Time frame: week 10
Quality of Life health related questionnaire. Scale 0-100
Time frame: week 20
Quality of Life health related questionnaire. Scale 0-100
Time frame: Baseline
Activity balance confidence scale. Scale has 16 items and is transferred to a percentage.
Time frame: week 10
Activity balance confidence scale. Scale has 16 items and is transferred to a percentage.
Time frame: week 20
Activity balance confidence scale. Scale has 16 items and is transferred to a percentage.
Time frame: Baseline
Questionnaire about walking in MS, 12 items, total score on 60, minimum score 12.
Time frame: week 10
Questionnaire about walking in MS, 12 items, total score on 60, minimum score 12.
Time frame: week 20
Questionnaire about walking in MS, 12 items, total score on 60, minimum score 12.
Time frame: Baseline
5 times sit to stand test, where patients have to stand and sit 5 times as fast as possible. Determined in seconds
Time frame: week 10
5 times sit to stand test, where patients have to stand and sit 5 times as fast as possible. Determined in seconds
Time frame: week 20
5 times sit to stand test, where patients have to stand and sit 5 times as fast as possible. Determined in seconds
Time frame: Baseline
patients have to walk 25 feet as fast as possible. Determined in seconds
Time frame: week 10
patients have to walk 25 feet as fast as possible. Determined in seconds
Time frame: week 20
patients have to walk 25 feet as fast as possible. Determined in seconds
Time frame: Baseline
Nine hole peck test: descriptive measure for hand dexterity. Measured in seconds.
Time frame: week 10
Nine hole peck test: descriptive measure for hand dexterity. Measured in seconds.
Time frame: week 20
Nine hole peck test: descriptive measure for hand dexterity. Measured in seconds.
Time frame: Baseline
patient have to perform several static and dynamic balance test. A four-point ordinal scale, ranging from 0-3. "0" indicates the lowest level of function and "3" the highest level of function. Total Score = 24
Time frame: week 10
patient have to perform several static and dynamic balance test. A four-point ordinal scale, ranging from 0-3. "0" indicates the lowest level of function and "3" the highest level of function. Total Score = 24
Time frame: week 20
patient have to perform several static and dynamic balance test. A four-point ordinal scale, ranging from 0-3. "0" indicates the lowest level of function and "3" the highest level of function. Total Score = 24
Time frame: Baseline
Dynamic gait index: patient have to perform several static and dynamic balance test. A ordinal scale, ranging from 0-2. "0" indicates the lowest level of function and "2" the highest level of function. Total Score = 48
Time frame: week 10
Dynamic gait index: patient have to perform several static and dynamic balance test. A ordinal scale, ranging from 0-2. "0" indicates the lowest level of function and "2" the highest level of function. Total Score = 48
Time frame: week 20
Dynamic gait index: patient have to perform several static and dynamic balance test. A ordinal scale, ranging from 0-2. "0" indicates the lowest level of function and "2" the highest level of function. Total Score = 48
Time frame: Baseline
Dual task testing during 1 min tasks and 6 minutes task to measure alertness of movement control.
Dual task testing during 1 min tasks and 6 minutes task to measure alertness of movement control.
Time frame: week 10
Dual task testing during 1 min tasks and 6 minutes task to measure alertness of movement control.
Dual task testing during 1 min tasks and 6 minutes task to measure alertness of movement control.
Time frame: week 20
Dual task testing during 1 min tasks and 6 minutes task to measure alertness of movement control.
Dual task testing during 1 min tasks and 6 minutes task to measure alertness of movement control.
Hasselt University
Other
Art for MS - Effects of a 10 Week Multimodal Dance and Art Intervention Program on Fatigue, Fatigability, and Their Related Factors - A Controlled Pilot-trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07680738
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Mexico City, Mexico
View Trial DetailsNCT04267926
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Portland, Oregon, United States
View Trial DetailsNCT06783413
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Tokat Province, Turkey (Türkiye)
View Trial DetailsNCT05848323
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Seattle, Washington, United States
View Trial Details